Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord Injury
DOSA-SCI
Dose-Optimization Study of Acute Intermittent Hypoxia (DOSA-SCI): Effects on Lower-Limb Motor Function and Physiological Responsiveness in Individuals With Incomplete Spinal Cord Injury
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to evaluate how different doses of acute intermittent hypoxia (AIH) affect lower-limb strength, reaction time, and responsiveness in individuals with spinal cord injury (SCI). The objective is to identify the dose that most effectively improves motor output while also examining parameters that may account for variability in response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 27, 2026
CompletedFirst Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
July 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
July 31, 2026
July 1, 2026
11 months
July 28, 2026
July 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in ankle plantarflexion and dorsiflexion
Measurement of ankle force during a maximum voluntary contraction while pushing or pulling on a force plate
Immediately following Intervention
Lower Limb Reaction time
Assessed using visual, auditory, and combined cueing tasks, reaction time will be quantified as the time from cue presentation to muscle activity onset
Immediately following intervention
Secondary Outcomes (2)
SpO2 burden
During intervention
Hypoxic Ventilatory Response
During intervention
Study Arms (3)
Sham + AIH 15 + AIH 23
OTHERIn this group, participants will undergo Sham AIH intervention first, with room oxygen, the following visit they will undergo 15, 60 second bouts of lowered oxygen, following that they will undergo 23, 60 second bouts of lowered oxygen
AIH 15 + Sham + AIH 23
OTHERIn this group, participants will undergo15, 60 second bouts of lowered oxygen intervention first, the following visit they will undergo sham training with room air, following that they will undergo 23, 60 second bouts of lowered oxygen
AIH 23 + AIH 15 + Sham
OTHERIn this group, participants will undergo 23, 60 second bouts of lowered oxygen intervention first, the following visit they will undergo 15, 60 second bouts of lowered oxygen, following that sham training with room air, following that they will undergo
Interventions
In this intervention, participants will wear a fitted mask, and will be given 15 bouts of room air through the same delivery system as the AIH interventions
In this intervention, participants will wear a fitted mask, and will be given 15, 60 second bouts of lowered oxygen (9% O2, akin to being on a tall mountain). Following the 60 seconds of hypoxia, participants will be given 60 seconds of room air
In this intervention, participants will wear a fitted mask, and will be given 23, 60 second bouts of lowered oxygen (9% O2, akin to being on a tall mountain). Following the 60 seconds of hypoxia, participants will be given 60 seconds of room air
Eligibility Criteria
You may qualify if:
- Chronic Spinal Cord Injury (\>6 months)
- Motor incomplete SCI classified as AIS C or D
- Volitional ankle plantarflexion strength in at least one leg
You may not qualify if:
- Uncontrolled hypertension (outside 140/90 and 90/60)
- Concurrent medical illness
- Traumatic brain injury
- Cardiovascular complications
- Pulmonary complications
- Metabolic dysfunction
- Continued use of anti-spasticity medications
- Previously diagnosed obstructive sleep apnea
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Milap Sandhulead
- Shirley Ryan AbilityLabcollaborator
Study Sites (1)
Shirley Ryan AbilityLab
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Milap Sandhu, PT, PhD
Shirley Ryan AbilityLab
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not know if they are receiving AIH or Sham AIH
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 28, 2026
First Posted
July 31, 2026
Study Start
July 27, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2028
Last Updated
July 31, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Within 3 years of close of study
- Access Criteria
- De-identified study data can be shared upon request by approved study staff
De-identified study data can be shared upon request